REGENXBIO Inc. (RGNX) Total liabilities 2016–2025
REGENXBIO Inc. (RGNX) total liabilities at each fiscal year-end, per SEC filings.
$350.3MFY2025 · since FY2016: $11.0M → $350.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $350.3M | +69.8% |
| FY2024 | $206.3M | -21.3% |
| FY2023 | $262.2M | -17.3% |
| FY2022 | $317.1M | -9.3% |
| FY2021 | $349.6M | +5.8% |
| FY2020 | $330.4M | +592.5% |
| FY2019 | $47.7M | +36.4% |
| FY2018 | $35.0M | +123.5% |
| FY2017 | $15.6M | +42.3% |
| FY2016 | $11.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice